Focus Partners Advisor Solutions LLC lifted its position in D.R. Horton, Inc. (NYSE:DHI – Free Report) by 53.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,510 shares of the construction company’s stock after acquiring an additional 4,376 shares during […]

Focus Partners Advisor Solutions LLC increased its holdings in MarketAxess Holdings Inc. (NASDAQ:MKTX – Free Report) by 60.7% in the 4th quarter, HoldingsChannel.com reports. The fund owned 13,082 shares of the financial services provider’s stock after buying an additional 4,942 shares during the period. Focus Partners Advisor Solutions LLC’s holdings in MarketAxess were worth $2,371,000 […]

Focus Partners Advisor Solutions LLC boosted its position in Deere & Company (NYSE:DE – Free Report) by 904.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,807 shares of the industrial products company’s stock after acquiring an additional 7,030 shares during […]

Focus Partners Advisor Solutions LLC grew its holdings in shares of Advanced Micro Devices, Inc. (NASDAQ:AMD – Free Report) by 65.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 25,890 shares of the semiconductor manufacturer’s stock after purchasing an additional 10,237 shares during the period. Focus Partners […]

Focus Partners Advisor Solutions LLC lessened its position in U.S. Bancorp (NYSE:USB – Free Report) by 20.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 76,988 shares of the financial services provider’s stock after selling 19,843 shares during the […]

Focus Partners Advisor Solutions LLC boosted its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 26.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 197,668 shares of the biopharmaceutical company’s stock after purchasing an additional 41,885 shares during the period. […]